Literature DB >> 230294

Topographical studies on poliovirus capsid proteins by chemical modification and cross-linking with bifunctional reagents.

K Wetz, K O Habermehl.   

Abstract

Poliovirus capsid proteins comprise 15.1 lysines in VP1, 5.6 lysines in VP2, 11.7 lysines in VP3 and 5.5 lysines in VP4. Treatment with monofunctional reagent N-succinimidyl 2,3-3H-proprionate leads to the modification of 3.4 lysines in VP1, 0.6 lysines in VP2, 2.0 lysines in VP3 and 0.03 lysines in VP4. Chemical modification with the monofunctional reagent N-succinimidyl 3-(4-hydroxy,5-125I-iodophenyl)propionate results in a predominant labelling of VP1 and VP3, whereas VP2 is less accessible and VP4 is not modified. Cross-linking of poliovirus with bifunctional imidoesters, dimethyl suberimidate (DMS, 1.1 nm) and dimethyl adipimidate (DMA, 0.8 nm) leads to a new protein complex of mol. wt. which corresponds to the sum of VP1 and VP3. By cleavage with ammonia and electrophoresis on polyacrylamide gels in SDS, the proteins are identified as VP1 and VP3. This result gives evidence for a direct neighbourhood of VP1 and VP3 in the virus capsid. Treatment of the virus with the mono- and bifunctional reagents has no influence on the stability of the particle. The infectivity is reduced only by the bifunctional reagent.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 230294     DOI: 10.1099/0022-1317-44-2-525

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus.

Authors:  O M Kew; M A Pallansch; D R Omilianowski; R R Rueckert
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

2.  In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain.

Authors:  M Kohara; T Omata; A Kameda; B L Semler; H Itoh; E Wimmer; A Nomoto
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

3.  Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies.

Authors:  M Chow; R Yabrov; J Bittle; J Hogle; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Genetic analysis of the attenuation phenotype of poliovirus type 1.

Authors:  T Omata; M Kohara; S Kuge; T Komatsu; S Abe; B L Semler; A Kameda; H Itoh; M Arita; E Wimmer
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

5.  Mechanism of action and capsid-stabilizing properties of VHHs with an in vitro antipolioviral activity.

Authors:  Lise Schotte; Mike Strauss; Bert Thys; Hadewych Halewyck; David J Filman; Mihnea Bostina; James M Hogle; Bart Rombaut
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

6.  Antigenic sites on foot-and-mouth disease virus type A10.

Authors:  A A Thomas; R J Woortmeijer; W Puijk; S J Barteling
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon.

Authors:  Wassim Chehadeh; Pierre-Emmanuel Lobert; Pierre Sauter; Anne Goffard; Bernadette Lucas; Jacques Weill; Marie-Christine Vantyghem; Gunnar Alm; Pascal Pigny; Didier Hober
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

8.  Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b.

Authors:  G Stanway; P J Hughes; R C Mountford; P Reeve; P D Minor; G C Schild; J W Almond
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

9.  Activity of glutaraldehyde at low concentrations against capsid proteins of poliovirus type 1 and echovirus type 25.

Authors:  M Chambon; J L Bailly; H Peigue-Lafeuille
Journal:  Appl Environ Microbiol       Date:  1992-11       Impact factor: 4.792

10.  Poliovirus empty capsid morphogenesis: evidence for conformational differences between self- and extract-assembled empty capsids.

Authors:  J R Putnak; B A Phillips
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.